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Reply
Sir,
We thank Stanley Shaldon for his critical comments on
our introductory paragraph about the history of home
haemodialysis. We have furthermore been informed by
Christopher Blagg that they started their home haemo-
dialysis program in Seattle also in 1964 (personal commu-
nication). We are in no position to judge whose claims about
the history of home haemodialysis are true and whose
are not. As a matter of fact, two of us weren’t even born
in 1961. Nevertheless, we think that the readers of
NDT should be provided with all the available data so that
each reader can decide themselves whose perception of truth
they will follow. We have to insist, however, that the
mountain climbed by the patient from Lauterbrunnen is
called ‘Mo¨nch’ and not Munck—a fact that can easily be
veriﬁed.
Division of Nephrology-Hypertension Dominik Uehlinger
University Hospital Bern
Switzerland
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Pseudohyperchloraemia due to bromvalerylurea abuse
Sir,
Electrolyte imbalance is one of most common causes of
unexplained neuropsychological manifestations, but dis-
turbed consciousness due to hyperchloraemia is very rare
today. Medication history is generally not easy to obtain
spontaneously while obtaining a patient’s history; clinicians
need to consider carefully the possibility of bromism due to
chronic bromide intoxication as one option in an insidious
toxic syndrome. We present a case of a patient who suffered
from progressive ataxia, dysarthria, dysphagia, delusions, and
auditory and visual hallucinations for a year. To our knowl-
edge, this is the ﬁrst case report of chronic bromvalerylurea
(BVU) intoxication presenting with pseudohyperchloraemia
in the English literature.
A 73-year-old man with no chronic disease history
developed incoherent speech and loss of short-time memory
1 year ago, dysarthria, deteriorated cognitive function and
frequent falls had also been noticed for 6 months. Ten days
before hospitalization, he was found lying on the ﬂoor at
home with residual consciousness, worsened dysarthria and
incoherent speech. Delirium was also noted over the following
days. On arrival at our Emergency Department, a neurolog-
ical examination revealed incoherent speech, disorientation
as to place and time, mild dysarthria, a poor gag reﬂex with
easy choking and gait disturbance (wide-based). His muscle
power was full and his bilateral deep tendon reﬂex, sensory
system and autonomic functions were intact. The Romberg’s
test was negative but he failed the tandem gait test. The
rapid alternative movement and ﬁnger–nose–ﬁnger tests
were done clumsily. Other aspects of the physical examination
were unremarkable. Initial laboratory studies revealed that
haemogram, electrolyte (including sodium, potassium and
calcium), liver function and renal function tests were all within
the normal range, except for a marked hyperchloraemia
(179mmol/l) and a negative anion gap (the calculated anion
gap [Naþ (ClþHCO3)] was 67.1mEq/l). The work-up
for the negative anion gap, including serum lithium level
(a suspicion of lithium toxicity), and electrophoresis
with immunoﬁxation (a suspicion of multiple myeloma)
were all negative. It should be noted that serum chloride
levels are rarely as high as that in our patient with lithium
toxicity or multiple myeloma. During hospitalization, he also
presented with persecutory delusion and bizarre behaviour, as
well as both visual and auditory hallucinations. Brain
magnetic resonance imaging (MRI) showed periventricular
leukoaraiosis and possible microangiopathy. An electroence-
phalogram (EEG) recording revealed patterns of moderate
diffuse cortical dysfunction.
A careful medication history inquiry with his family
revealed the patient took ‘Ming-Tong Chih Tong Dan
(MTCTD)’, a non-steroidal anti-inﬂammatory drug
(NSAID) containing BVU that is sold over the counter. He
had taken 4–5 packages of this drug daily for about 5–6 years
to treat his persistent headache; this drug contains ethoxy-
benzamide (350mg), caffeine anhydrous (50mg), acetamin-
ophen (200mg) and BVU (200mg) per package. Six months
prior to admission, the total daily dosage had been gradually
increased to 10–15 packages per day due to a worsening of
the headache.
We examined the serum at 11 days after the last dose
of MTCTD and the result showed a bromide level of
101.5±1.9mg/dl, measured by inductively coupled plasma
mass spectrometry (ICP-MS). Forced diuresis with intra-
venous normal saline, as well as intravenous furosemide was
carried out. The neurological symptoms and signs (dysar-
thria, delirium and cerebellar ataxia) recovered rapidly over
the next 3–5 days. Repeat analysis at 24 days after the last
dose ofMTCTD showed that the serum chloride and bromide
levels had declined [chloride, 104mmol/l measured by an
ion-selective electrode (ISE); and bromide, 6.15±2.6mg/dl
measured by ICP-MS]. Two weeks later, his score on the
Mini-Mental State Examination (MMSE) showed a signiﬁ-
cant improvement. Occasional cases of bromide intoxication
have been reported previously [1–6], mainly due to the use of
bromide-containing products in non-prescription prepara-
tions, such as analgesic, antitussive or anti-epileptic drugs.
As with our patient, most diagnoses were aided by a negative
anion gap and hyperchloraemia, because bromide is always
regarded as chloride by automated analysis when measure-
ment is by an ISE. The ISE method results in a higher
apparent chloride concentration in sera when it also contains
bromide or another halide [6].
The neurological manifestations seem to be dose related,
but the correlation between the blood level of bromide and
its toxicity is uncertain. A serum level >20mg/dl is considered
toxic [4]. Bromides have a long half-life (10–14 days) and
the ion is eliminated mainly through the kidney. The half-life
can be reduced from 12 days to <3 days with saline diuresis
alone [7] and 1–2 h with haemodialysis therapy [3]. Although
emergent haemodialysis is very effective due to the rapid
clearance that occurs [5], it is unusual to use this as the ﬁrst
choice because most patients respond well to saline diuresis.
In conclusion, although bromism is rare today, a review
of the patient’s medical history for bromide-containing
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